Roche at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
Roche takes part in 35 sessions at BioTechX Europe 2026 in Basel, its home city. Its program spans getting research data ready for AI, clinical trials, real-world patient data and digital health. Concrete topics include using generative AI to write first drafts of clinical documents in ten minutes and validating AI agents against drug-industry quality rules before they work on clinical data.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
Roche Basel, Switzerland | |
Swiss healthcare company developing pharmaceuticals and diagnostics. | Chair Tue Oct 6 11:40 Talk Tue Oct 6 12:05 Talk Tue Oct 6 12:25 Talk Tue Oct 6 13:05 Talk Tue Oct 6 13:05 Chair Tue Oct 6 15:25 Talk Tue Oct 6 15:30 Talk Tue Oct 6 15:50 Data Management in the era of AI - What it takes to deliver value at scale Why AI assistants give wrong answers from correct company data, and how to supply the context people once filled in themselves. Talk Tue Oct 6 15:50 Panel Tue Oct 6 16:10 Talk Tue Oct 6 16:30 Talk Tue Oct 6 16:30 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Talk Wed Oct 7 12:05 Talk Wed Oct 7 12:25 Building Responsible AI: Lessons for Life Sciences How life sciences companies can manage the risks of large language models and prepare for AI that acts on its own. Talk Wed Oct 7 12:25 Talk Wed Oct 7 13:05 Roche approach to modernize shop floor operations with AI How Roche is replacing paper logs at its manufacturing sites with real-time digital records and a chat-based AI assistant for workers. Chair Wed Oct 7 15:25 Talk Wed Oct 7 15:30 Talk Wed Oct 7 15:30 AI, you, and the future of work What kinds of work AI will reshape and how employees and leaders can adopt it, with Klarna and Ikea as examples. Talk Wed Oct 7 15:30 Talk Wed Oct 7 15:50 Talk Wed Oct 7 15:50 Talk Wed Oct 7 16:30 Panel Wed Oct 7 17:25 Panel Wed Oct 7 17:25 Chair Thu Oct 8 11:05 Talk Thu Oct 8 11:10 Evaluating Data Utility in Anonymization, Federated Approaches, and OMOP-CDM Testing how much a breast cancer study's data stays useful after being anonymized, split across sites, or converted to a shared format. Talk Thu Oct 8 11:30 Talk Thu Oct 8 12:10 From Awareness to Adoption: Driving Change Beyond the Go-Live Why telling staff about a new system is not enough, and how to help them truly adopt it after launch. |
Instantly find 20 buyers from Roche
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction